Group One Trading’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
|
|||||
|
2025
Q1 | – | Hold |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $16.2K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $37.8K | Sell |
|
|||||
|
2023
Q4 | $61.6K | Sell |
|
|||||
|
2023
Q3 | $101K | Sell |
|
|||||
|
2023
Q2 | $153K | Sell |
|
|||||
|
2023
Q1 | $149K | Sell |
|
|||||
|
2022
Q4 | $215K | Sell |
|
|||||
|
2022
Q3 | $131K | Sell |
|
|||||
|
2022
Q2 | $165K | Buy |
|
|||||
|
2022
Q1 | $289K | Buy |
|
|||||
|
2021
Q4 | $148K | Buy |
|
|||||
|
2021
Q3 | $60K | Buy |
|
|||||
|
2021
Q2 | $66K | Sell |
|
|||||
|
2021
Q1 | $181K | Sell |
|
|||||
|
2020
Q4 | $265K | Buy |
|
|||||
|
2020
Q3 | $87K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $637K | Buy |
|
|||||
|
2019
Q4 | $405K | Sell |
|
|||||
|
2019
Q3 | $267K | Sell |
|
|||||
|
2019
Q2 | $339K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $45K | Sell |
|
|||||
|
2018
Q3 | $115K | Buy |
|
|||||
|
2018
Q2 | $117K | Buy |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $112K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $236K | Buy |
|
|||||
|
2016
Q4 | $119K | Sell |
|
|||||
|
2016
Q3 | $271K | Buy |
|
|||||
|
2016
Q2 | $183K | Buy |
|
|||||
|
2016
Q1 | $156K | Buy |
|
|||||
|
2015
Q4 | $93K | Sell |
|
|||||
|
2015
Q3 | $126K | Buy |
|
|||||
|
2015
Q2 | $90K | Sell |
|
|||||
|
2015
Q1 | $142K | Buy |
|
|||||
|
2014
Q4 | $132K | Buy |
|
|||||
|
2014
Q3 | $5K | Buy |
|